Quarterly report pursuant to Section 13 or 15(d)

Stock-based Payments (Tables)

v3.22.2.2
Stock-based Payments (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options Activity

The following table summarizes the activities for MyMD stock options for the nine months ended September 30, 2022:

                      Weighted        
                      Average        
          Weighted     Weighted     Remaining        
    Number     Average     Average     Contractual     Aggregate  
    of     Exercise     Grant Date     Term     Intrinsic  
    Shares     Price     Fair Value     (years)     Value  
Balance at December 31, 2021     4,176,737     $ 2.59     $ 2.59       1.29     $ 14,493,284  
Granted     300,000       3.41       3.41       5.80     $ 31,000  
Exercised     -       -       -       -       -  
Forfeited     -       -       -       -       -  
Canceled/Expired     -       -       -       -       -  
Balance at September 30, 2022     4,476,737       2.64       2.64       0.89     $ 114,535  
Exercisable as of September 30, 2022     4,376,737       2.61       2.61       0.77     $ 114,535  
Summary of Restricted Stock Units Activity

The following is the status of outstanding restricted stock units outstanding as of September 30, 2022 and changes for the nine months ended September 30, 2022:

 

          Weighted  
          Average  
    Number of     Grant Date  
    RSUs     Fair Value  
Balance at December 31, 2021     2,795,000     $ 8.09  
Granted     54,207       3.06  
Exercised     -       -  
Forfeited     -       -  
Canceled/Expired     -       -  
Balance at September 30, 2022   $ 2,849,207     $ 7.99  
Exercisable as of September 30, 2022   $ 54,207     $ 3.06